Description 5-Amino-1MQ is positioned in research contexts as an NNMT (nicotinamide N-methyltransferase) pathway small molecule, not an NMN (nicotinamide mononucleotide) profile, with interpretation generally anchored to broader NNMT inhibition literature
Subcutaneous use is uncommon and dose-limited
Effects observed in rat tendon-healing models or rodent gastric-ulcer assays cannot be assumed to occur, at the same magnitude, or with the same safety profile, in humans
Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies [2] [3]
More serious deficiencies have the potential to impair heart and neurological function, leading to a wide range of serious symptoms, including but not limited to tinnitus, severe joint pain, memory problems, depression, anxiety, poor muscle function, ataxia and changes in reflexes